Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who...
from NDTV News - World-news https://ift.tt/36PjXS6
Resent New
Discord abandons Microsoft acquisition talks: Report
Discussion platform Discord, popular among amateur video game players, has halted acquisition talks with Microsoft and is instead considerin...
